Considering that the SA Health Products Regulatory Authority is blocking companies (details furnished) from importing Meloxicam BP for compounding purposes, despite the fact that SAHPRA’s reasoning is apparently based on a faulty interpretation of the law (details furnished), what are the reasons that SAHPRA is blocking the importing of Meloxicam BP for compounding purposes?